The emerging therapy of tirzepatide peptide represents a exciting development in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide411350.blogdomago.com/40470886/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment